NYSE:CVS - CVS Health Stock Price, Forecast & News

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health announced a quarterly dividend on Thursday, January 2nd. Stockholders of record on Thursday, January 23rd will be paid a dividend of $0.50 per share on Monday, February 3rd. This represents a $2.00 annualized dividend and a dividend yield of 2.70%. The ex-dividend date of this dividend is Wednesday, January 22nd. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) announced its quarterly earnings data on Wednesday, November, 6th. The pharmacy operator reported $1.84 earnings per share for the quarter, beating the consensus estimate of $1.77 by $0.07. The pharmacy operator earned $64.81 billion during the quarter, compared to analysts' expectations of $62.99 billion. CVS Health had a return on equity of 15.45% and a net margin of 1.83%. CVS Health's revenue for the quarter was up 36.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.73 EPS. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for CVS Health.

CVS Health updated its FY19 earnings guidance on Wednesday, November, 6th. The company provided EPS guidance of $6.97-7.05 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.98.

24 brokerages have issued 12-month price objectives for CVS Health's shares. Their forecasts range from $61.00 to $97.00. On average, they anticipate CVS Health's stock price to reach $77.43 in the next twelve months. This suggests a possible upside of 4.6% from the stock's current price. View Analyst Price Targets for CVS Health.

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 6 hold ratings, 17 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

News stories about CVS stock have trended somewhat positive this week, according to InfoTrie Sentiment. The research group scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CVS Health earned a coverage optimism score of 1.0 on InfoTrie's scale. They also gave news stories about the pharmacy operator a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for CVS Health.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Covetrus (CVET), Rite Aid (RAD), Petmed Express (PETS), 111 (YI), Diplomat Pharmacy (DPLO), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), Cisco Systems (CSCO), NVIDIA (NVDA), Alibaba Group (BABA), Home Depot (HD), Verizon Communications (VZ), Johnson & Johnson (JNJ), Bank of America (BAC) and Intel (INTC).

CVS Health's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Hexavest Inc. (0.09%), SPF Beheer BV (0.09%), Artemis Investment Management LLP (0.06%), Janney Montgomery Scott LLC (0.06%), Country Trust Bank (0.05%) and Gateway Investment Advisers LLC (0.05%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, Helena Foulkes, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Troyen A Brennan and Vost Collin. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Rhenman & Partners Asset Management AB, Coronation Fund Managers Ltd., Commerzbank Aktiengesellschaft FI, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Janney Montgomery Scott LLC, Hexavest Inc. and Loring Wolcott & Coolidge Fiduciary Advisors LLP MA. Company insiders that have sold CVS Health company stock in the last year include Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Larry J Merlo and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was purchased by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Artemis Investment Management LLP, Johanson Financial Advisors Inc., Zurcher Kantonalbank Zurich Cantonalbank, Corbenic Partners LLC, F&V Capital Management LLC, Sanders Morris Harris LLC and Country Trust Bank. Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $74.01.

CVS Health has a market capitalization of $96.28 billion and generates $194.58 billion in revenue each year. The pharmacy operator earns $-594,000,000.00 in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 295,000 workers across the globe.View Additional Information About CVS Health.

The official website for CVS Health is http://www.cvshealth.com/.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]